Position in BMRN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,328,873
-$11,358,075 QoQ
Shares Held
197,988
-50.7% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#112
of 564 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $230,687,600 across 99 Biotechnology names. BMRN ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
424,682 | $48,141,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,105 | $29,995,391 | |
| 3 | EXEL |
Exelixis, Inc.
|
451,768 | $24,580,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,339 | $18,547,400 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
197,988 | $11,328,873 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
58,834 | $11,018,430 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
92,394 | $8,033,658 | |
| 8 | BHVN |
Biohaven Ltd.
|
475,865 | $7,080,871 |
All Filings in BMRN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,328,873 | 197,988 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $22,686,948 | 401,610 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $21,279,268 | 358,056 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $22,710,425 | 419,321 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $14,051,376 | 255,619 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $11,633,877 | 164,576 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $3,962,664 | 60,287 | Shares | Other | 2025-02-03 | |
| 2024-09-30 | $501,589 | 7,136 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||